Oregon 2025 Regular Session

Oregon House Bill HB3226

Introduced
1/13/25  
Refer
1/17/25  
Report Pass
4/7/25  
Engrossed
4/15/25  
Refer
4/15/25  
Report Pass
5/20/25  

Caption

Relating to organizations that provide services related to obtaining prescription drugs; and prescribing an effective date.

Impact

If enacted, HB3226 would significantly alter the existing framework governing organizations that facilitate prescription drug acquisition. By establishing clear guidelines and standards, the bill would enhance accountability among service providers, potentially leading to better patient outcomes. The legislation is expected to streamline processes and provide clearer pathways for patients seeking prescription drugs, thereby improving the overall healthcare experience.

Summary

House Bill 3226 aims to enhance patient access to prescription drugs by regulating organizations that provide services related to obtaining these medications. The legislation seeks to define the roles and responsibilities of such organizations, ensuring that patients can receive the necessary support in managing their prescription needs efficiently. This bill is focused on improving the relationship between healthcare providers and patients, minimizing barriers to accessing vital medications.

Sentiment

The overall sentiment surrounding HB3226 appears to be positive, particularly among healthcare advocates and patient rights organizations. Supporters believe that the bill represents a crucial step in addressing the challenges patients face when accessing prescription medications. Nevertheless, there are concerns among some healthcare providers who worry about the implications of increased regulation and potential administrative burdens that could arise from the bill's implementation.

Contention

Notable points of contention regarding HB3226 involve the balance between necessary regulation and the flexibility that organizations need to operate effectively. Critics express concerns about whether the regulations might hinder the ability of some organizations to function optimally, leading to potential delays in patient access to medications. The debate reflects a broader discussion about how best to ensure a safe and efficient healthcare system while fostering innovation and responsiveness in service delivery.

Companion Bills

No companion bills found.

Similar Bills

LA HB432

Provides for the regulation of pharmacy services administrative organizations (OR +$88,000 SG EX See Note)

LA HB387

Provides for the regulation of pharmacy services administrative organizations

AR SB475

To Establish The Pharmacy Services Administrative Organization Act; And To Regulate Pharmacy Services Administrative Organizations.

AR SB593

To Amend The Arkansas Pharmacy Benefits Manager Licensure Act; And To Create The Pharmacy Services Administrative Organization Act.

TX HB2479

Relating to the authority and rights of pharmacy services administrative organizations to conduct the business of independent pharmacies with respect to certain pharmacy benefits.

TX SB1176

Relating to the authority and rights of pharmacy services administrative organizations to conduct the business of independent pharmacies with respect to certain pharmacy benefits.

LA HB244

Provides for the regulation of pharmacy services administrative organizations

MS HB987

Pharmacy Benefit Prompt Pay Act; revise various provisions of.